Axplora- The partner of choice for complex APIs.
01 2Farmabios S.p.A.
02 1Amphastar Nanjing Pharmaceuticals, Inc.
03 1Bayer AG
04 2Curia Spain, S.A.U.
05 1Hubei Gedian humanwell Pharmaceutical Co., Ltd
06 1LETCO MEDICAL, LLC
07 2Pharmacia and Upjohn Company LLC
08 1STERLING SPA
09 1Sicor de Mexico S.A. de C.V
10 1Sotera Health LLC
11 1Zhejiang Xianju Pharmaceutical Co., Ltd.
01 3MEDROXYPROGESTERONE ACETATE
02 1Medroxyprogesterone
03 3Medroxyprogesterone Acetate
04 6Medroxyprogesterone acetate
05 1medroxyprogesterone acetate
01 2China
02 3Germany
03 1Italy
04 1Mexico
05 7U.S.A
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8712
Start Marketing Date : 1992-02-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8749
Start Marketing Date : 2015-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52221-118
Start Marketing Date : 2016-10-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12866-1099
Start Marketing Date : 2017-05-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-017
Start Marketing Date : 2024-04-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-1474
Start Marketing Date : 2011-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0009-0067
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-5097
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-0089
Start Marketing Date : 2018-10-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60722-1006
Start Marketing Date : 2017-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A CAS-71-58-9 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-71-58-9, including repackagers and relabelers. The FDA regulates CAS-71-58-9 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-71-58-9 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-71-58-9 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-71-58-9 supplier is an individual or a company that provides CAS-71-58-9 active pharmaceutical ingredient (API) or CAS-71-58-9 finished formulations upon request. The CAS-71-58-9 suppliers may include CAS-71-58-9 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-71-58-9 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-71-58-9 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-71-58-9 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-71-58-9 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-71-58-9 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-71-58-9 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-71-58-9 suppliers with NDC on PharmaCompass.
We have 11 companies offering CAS-71-58-9
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
